Cramer: Rare biotechs that stumped me

Jim Cramer went back to the drawing board and presented his research on the rare biotechs that stumped him last month. Time to hold 'em or fold 'em?
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.